Effect of Systemic Immunomodulators on Incidence of Alopecia Areata: A Retrospective Cohort Study
July 2025
in “
Journal of Investigative Dermatology
”
Studysummary Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jidonline.org →